Loading the security overview…
Where the tokens are
What AbbVie has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 3, 2026 | 8-K | Current report | On SEC.gov |
| Aug 18, 2026 | 8-K | Current report | On SEC.gov |
| Aug 5, 2026 | 8-K | Current report | On SEC.gov |
| Aug 3, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Jul 31, 2026 | 8-K | Current report | On SEC.gov |
| Jul 6, 2026 | 8-K | Current report | On SEC.gov |
| Jun 22, 2026 | 8-K | Current report | On SEC.gov |
| May 12, 2026 | 8-K | Current report | On SEC.gov |
| May 8, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Apr 29, 2026 | 8-K | Current report | On SEC.gov |
| Apr 3, 2026 | 8-K | Current report | On SEC.gov |
| Mar 4, 2026 | 8-K | Current report | On SEC.gov |
| Feb 26, 2026 | 8-K | Current report | On SEC.gov |
| Feb 20, 2026 | 10-K | Annual report | On SEC.gov |
| Feb 4, 2026 | 8-K | Current report | On SEC.gov |
| Jan 7, 2026 | 8-K | Current report | On SEC.gov |
| Nov 4, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Oct 31, 2025 | 8-K | Current report | On SEC.gov |
| Oct 3, 2025 | 8-K | Current report | On SEC.gov |
| Sep 11, 2025 | 8-K | Current report | On SEC.gov |
| Aug 4, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Jul 31, 2025 | 8-K | Current report | On SEC.gov |
| Jul 3, 2025 | 8-K | Current report | On SEC.gov |
| May 13, 2025 | 8-K | Current report | On SEC.gov |
| May 9, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Apr 25, 2025 | 8-K | Current report | On SEC.gov |
| Apr 3, 2025 | 8-K | Current report | On SEC.gov |
| Feb 26, 2025 | 8-K | Current report | On SEC.gov |
| Feb 19, 2025 | 8-K | Current report | On SEC.gov |
| Feb 14, 2025 | 10-K | Annual report | On SEC.gov |
| Feb 14, 2025 | 8-K | Current report | On SEC.gov |
| Feb 5, 2025 | 8-K | Current report | On SEC.gov |
| Jan 31, 2025 | 8-K | Current report | On SEC.gov |
| Jan 10, 2025 | 8-K | Current report | On SEC.gov |
| Jan 6, 2025 | 8-K | Current report | On SEC.gov |
| Dec 13, 2024 | 8-K | Current report | On SEC.gov |
| Nov 4, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Oct 30, 2024 | 8-K | Current report | On SEC.gov |
| Oct 3, 2024 | 8-K | Current report | On SEC.gov |
| Sep 10, 2024 | 8-K | Current report | On SEC.gov |
| Aug 7, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Jul 25, 2024 | 8-K | Current report | On SEC.gov |
| Jul 3, 2024 | 8-K | Current report | On SEC.gov |
| May 3, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Apr 26, 2024 | 8-K | Current report | On SEC.gov |
| Apr 3, 2024 | 8-K | Current report | On SEC.gov |
| Feb 26, 2024 | 8-K | Current report | On SEC.gov |
| Feb 20, 2024 | 10-K | Annual report | On SEC.gov |
| Feb 20, 2024 | 8-K | Current report | On SEC.gov |
| Feb 12, 2024 | 8-K | Current report | On SEC.gov |
| Feb 2, 2024 | 8-K | Current report | On SEC.gov |
| Jan 5, 2024 | 8-K | Current report | On SEC.gov |
| Dec 6, 2023 | 8-K | Current report | On SEC.gov |
| Nov 30, 2023 | 8-K | Current report | On SEC.gov |
| Nov 6, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Oct 27, 2023 | 8-K | Current report | On SEC.gov |
| Oct 12, 2023 | 8-K | Current report | On SEC.gov |
| Oct 4, 2023 | 8-K | Current report | On SEC.gov |
| Aug 7, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Jul 27, 2023 | 8-K | Current report | On SEC.gov |
Figures describe AbbVie shares, not any token. As of Sep 3, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.